Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
News
Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions
Biosenta Closes Private Placement Financing
Biosenta Announces Private Placement Financing
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Fillerâ„¢ Particle Encapsulation Technology
Amarvir Gill Holdings in Biosenta Inc.
Biosenta Announces Closing of Previously Announced Transaction
Biosenta Announces Debt Settlement
Biosenta Announces Engagement of Oak Hill Financial Inc.
Biosenta closes private placement financing
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillerâ„¢
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta announces further advances in research and development of Tri-Fillerâ„¢
Biosenta announces termination of joint venture and issuance of securities
Biosenta announces entering into of agreement to terminate joint venture
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.
Biosenta Inc. enters into an MOU with Voran Group Ventures Ltd.
Biosenta Annual Meeting 2022
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
Biosenta Announces Shares for Debt Settlement